T1	Participants 73 127	patients treated with anthracycline-based chemotherapy
T2	Participants 303 339	patients treated with anthracyclines
T3	Participants 434 473	42 patients treated with anthracyclines
T4	Participants 554 572	healthy volunteers
T5	Participants 620 847	21 men and 21 women with a mean age of 55 ± 17 years, who presented a median of 84 months after chemotherapy with a cumulative anthracycline exposure of 282 ± 65 mg/m(2) and a mean left ventricular ejection fraction of 52 ± 12%
T6	Participants 1284 1330	patients with previous anthracycline treatment
